1. Home
  2. PB vs BLCO Comparison

PB vs BLCO Comparison

Compare PB & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prosperity Bancshares Inc.

PB

Prosperity Bancshares Inc.

N/A

Current Price

$67.34

Market Cap

7.1B

Sector

Finance

ML Signal

N/A

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

N/A

Current Price

$17.23

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PB
BLCO
Founded
1983
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.0B
IPO Year
1998
2022

Fundamental Metrics

Financial Performance
Metric
PB
BLCO
Price
$67.34
$17.23
Analyst Decision
Buy
Buy
Analyst Count
14
12
Target Price
$79.54
$18.55
AVG Volume (30 Days)
1.1M
454.5K
Earning Date
04-29-2026
05-21-2026
Dividend Yield
3.50%
N/A
EPS Growth
13.27
N/A
EPS
5.72
N/A
Revenue
N/A
$5,101,000,000.00
Revenue This Year
$41.06
$8.61
Revenue Next Year
$17.19
$5.52
P/E Ratio
$12.02
N/A
Revenue Growth
N/A
6.47
52 Week Low
$61.07
$10.45
52 Week High
$77.20
$18.92

Technical Indicators

Market Signals
Indicator
PB
BLCO
Relative Strength Index (RSI) 33.87 44.12
Support Level $64.61 $16.35
Resistance Level $67.56 $17.66
Average True Range (ATR) 1.79 0.52
MACD -0.56 -0.14
Stochastic Oscillator 9.89 17.57

Price Performance

Historical Comparison
PB
BLCO

About PB Prosperity Bancshares Inc.

Prosperity Bancshares Inc provides retail and commercial banking services to individuals and small to midsize businesses. It provides a wide array of financial products and services to businesses and consumers throughout Texas and Oklahoma. The group provides Personal, Business, Mortgage, and Banking Services.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: